Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Pharmacol Biochem Behav. 2011 Sep 25;100(3):607–615. doi: 10.1016/j.pbb.2011.09.009

Fig. 3.

Fig. 3

Forepaw adjusting steps test (FAS) in L-DOPA-primed DA (n = 10) and DA + NE (n = 9) lesioned rats. Both lesion groups received either Vehicle or L-DOPA (4 mg/kg + Bensarazide 15 mg/kg) 60 min prior to the FAS test in a counterbalanced design. Bars show the effects of treatments on FAS performance expressed as mean percentages of intact forepaw adjusting steps ± S.E.M. Effects were analyzed by a 2 (Lesion) × 2 (Treatment) ANOVA. In both Lesion groups, L-DOPA improved stepping vs. Vehicle. *P<0.05 vs Vehicle.